<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">38892479</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>19</Day></DateCompleted><DateRevised><Year>2024</Year><Month>06</Month><Day>25</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>May</Month><Day>21</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>A Narrative Review on Gut Microbiome Disturbances and Microbial Preparations in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Implications for Long COVID.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1545</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu16111545</ELocationID><Abstract><AbstractText>Myalgic encephalomyelitis, also known as chronic fatigue syndrome (ME/CFS), and long COVID are complex, multisystemic and long-term disabling conditions characterized by debilitating post-exertional malaise and other core symptoms related to immune dysregulation resultant from post-viral infection, including mitochondrial dysfunction, chronic neuroinflammation and gut dysbiosis. The reported associations between altered microbiota composition and cardinal symptoms of ME/CFS and long COVID suggest that the use of microbial preparations, such as probiotics, by restoring the homeostasis of the brain-immune-gut axis, may help in the management of symptoms in both conditions. Therefore, this review aims to investigate the implications of alerted gut microbiome and assess the evidence supporting use of microbial-based preparations, including probiotics, synbiotics, postbiotics alone and/or in combination with other nutraceuticals in the management of fatigue, inflammation and neuropsychiatric and gastrointestinal symptoms among patients with ME/CFS and long COVID.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jurek</LastName><ForeName>Joanna Michalina</ForeName><Initials>JM</Initials><Identifier Source="ORCID">0000-0002-7319-0672</Identifier><AffiliationInfo><Affiliation>Unit of Research in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID, Rheumatology Research Division, Vall d'Hebron Research Institute, Universitat Aut&#xf2;noma de Barcelona, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Grup de Recerca GEMMAIR (AGAUR)-Medicina Aplicada (URV), Departament de Medicina i Cirurgia, Institut d'Investigaci&#xf3; Sanit&#xe0;ria Pere Virgili, Universitat Rovira i Virgili, 43005 Tarragona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro-Marrero</LastName><ForeName>Jesus</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-2481-3052</Identifier><AffiliationInfo><Affiliation>Unit of Research in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID, Rheumatology Research Division, Vall d'Hebron Research Institute, Universitat Aut&#xf2;noma de Barcelona, 08035 Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="Y">Probiotics</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D064806" MajorTopicYN="Y">Dysbiosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019587" MajorTopicYN="N">Dietary Supplements</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058616" MajorTopicYN="N">Synbiotics</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration &amp; dosage</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000087502" MajorTopicYN="N">Brain-Gut Axis</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antioxidants</Keyword><Keyword MajorTopicYN="N">chronic fatigue syndrome</Keyword><Keyword MajorTopicYN="N">dietary supplementation</Keyword><Keyword MajorTopicYN="N">gut microbiota</Keyword><Keyword MajorTopicYN="N">gut&#x2013;brain axis</Keyword><Keyword MajorTopicYN="N">inflammation</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">myalgic encephalomyelitis</Keyword><Keyword MajorTopicYN="N">prebiotics</Keyword><Keyword MajorTopicYN="N">probiotics</Keyword><Keyword MajorTopicYN="N">psychobiotics</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>5</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>19</Day><Hour>1</Hour><Minute>11</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38892479</ArticleId><ArticleId IdType="pmc">PMC11173566</ArticleId><ArticleId IdType="doi">10.3390/nu16111545</ArticleId><ArticleId IdType="pii">nu16111545</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Germain A., Barupal D.K., Levine S.M., Hanson M.R. Comprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids. Metabolites. 2020;10:34. doi: 10.3390/metabo10010034.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo10010034</ArticleId><ArticleId IdType="pmc">PMC7023305</ArticleId><ArticleId IdType="pubmed">31947545</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;nig R.S., Albrich W.C., Kahlert C.R., Bahr L.S., L&#xf6;ber U., Vernazza P., Scheibenbogen C., Forslund S.K. The Gut Microbiome in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Front. Immunol. 2022;12:628741. doi: 10.3389/fimmu.2021.628741. Erratum in Front. Immunol. 2022, 13, 878196.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.628741</ArticleId><ArticleId IdType="pmc">PMC8761622</ArticleId><ArticleId IdType="pubmed">35046929</ArticleId></ArticleIdList></Reference><Reference><Citation>Lakhan S.E., Kirchgessner A. Gut inflammation in chronic fatigue syndrome. Nutr. Metab. 2010;7:79. doi: 10.1186/1743-7075-7-79.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-7075-7-79</ArticleId><ArticleId IdType="pmc">PMC2964729</ArticleId><ArticleId IdType="pubmed">20939923</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirin A.A., Dimmock M.E., Jason L.A. Research update: The relation between ME/CFS disease burden and research funding in the USA. Work. 2020;66:277&#x2013;282. doi: 10.3233/WOR-203173.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/WOR-203173</ArticleId><ArticleId IdType="pubmed">32568148</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandler C.X., Lloyd A.R. Chronic fatigue syndrome: Progress and possibilities. Med. J. Aust. 2020;212:428&#x2013;433. doi: 10.5694/mja2.50553.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja2.50553</ArticleId><ArticleId IdType="pubmed">32248536</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., McManimen S., Sunnquist M., Brown A., Newton J.L., Strand E.B. Examining the institute of medicine&#x2019;s recommendations regarding chronic fatigue syndrome: Clinical versus research criteria. J. Neurol. Psychol. 2015;2015((Suppl. S2))</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5008852</ArticleId><ArticleId IdType="pubmed">27595126</ArticleId></ArticleIdList></Reference><Reference><Citation>Barry P.W., Kelley K., Tan T., Finlay I. NICE guideline on ME/CFS: Robust advice based on a thorough review of the evidence. J. Neurol. Neurosurg. Psychiatry. 2024 doi: 10.1136/jnnp-2023-332731.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2023-332731</ArticleId><ArticleId IdType="pubmed">38418217</ArticleId></ArticleIdList></Reference><Reference><Citation>Devasahayam A., Lawn T., Murphy M., White P.D. Alternative diagnoses to chronic fatigue syndrome in referrals to a specialist service: Service evaluation survey. JRSM Short Rep. 2012;3:4. doi: 10.1258/shorts.2011.011127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1258/shorts.2011.011127</ArticleId><ArticleId IdType="pmc">PMC3269106</ArticleId><ArticleId IdType="pubmed">22299071</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients after Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Lipkin W.I. ME/CFS and Long COVID share similar symptoms and biological abnormalities: Road map to the literature. Front. Med. 2023;10:1187163. doi: 10.3389/fmed.2023.1187163.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1187163</ArticleId><ArticleId IdType="pmc">PMC10278546</ArticleId><ArticleId IdType="pubmed">37342500</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>White P.D., Thomas J.M., Amess J., Crawford D.H., Grover S.A., Kangro H.O., Clare A.W. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br. J. Psychiatry. 1998;173:475&#x2013;481. doi: 10.1192/bjp.173.6.475.</Citation><ArticleIdList><ArticleId IdType="doi">10.1192/bjp.173.6.475</ArticleId><ArticleId IdType="pubmed">9926075</ArticleId></ArticleIdList></Reference><Reference><Citation>Tate W.P., Walker M.O., Peppercorn K., Blair A.L., Edgar C.D. Towards a better understanding of the complexities of myalgic encephalomyelitis/chronic fatigue syndrome and long COVID. Int. J. Mol. Sci. 2023;24:5124. doi: 10.3390/ijms24065124.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24065124</ArticleId><ArticleId IdType="pmc">PMC10048882</ArticleId><ArticleId IdType="pubmed">36982194</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandarano A.H., Maya J., Giloteaux L., Peterson D.L., Maynard M., Gottschalk C.G., Hanson M.R. Myalgic encephalomyelitis/chronic fatigue syndrome patients exhibit altered T cell metabolism and cytokine associations. J. Clin. Investig. 2020;130:1491&#x2013;1505. doi: 10.1172/JCI132185.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI132185</ArticleId><ArticleId IdType="pmc">PMC7269566</ArticleId><ArticleId IdType="pubmed">31830003</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang E.Y., Mao T., Klein J., Dai Y., Huck J.D., Jaycox J.R., Liu F., Zhou T., Israelow B., Wong P., et al. Diverse functional autoantibodies in patients with COVID-19. Nature. 2021;595:283&#x2013;288. doi: 10.1038/s41586-021-03631-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03631-y</ArticleId><ArticleId IdType="pubmed">34010947</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryabkova V.A., Gavrilova N.Y., Poletaeva A.A., Pukhalenko A.I., Koshkina I.A., Churilov L.P., Shoenfeld Y. Autoantibody correlation signatures in fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: Association with symptom severity. Biomedicines. 2023;11:257. doi: 10.3390/biomedicines11020257.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biomedicines11020257</ArticleId><ArticleId IdType="pmc">PMC9952981</ArticleId><ArticleId IdType="pubmed">36830795</ArticleId></ArticleIdList></Reference><Reference><Citation>Sotzny F., Blanco J., Capelli E., Castro-Marrero J., Steiner S., Murovska M., Scheibenbogen C. Myalgic encephalomyelitis/chronic fatigue syndrome: Evidence for an autoimmune disease. Autoimmun. Rev. 2018;17:601&#x2013;609. doi: 10.1016/j.autrev.2018.01.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2018.01.009</ArticleId><ArticleId IdType="pubmed">29635081</ArticleId></ArticleIdList></Reference><Reference><Citation>Maksoud R., Magawa C., Eaton-Fitch N., Thapaliya K., Marshall-Gradisnik S. Biomarkers for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): A systematic review. BMC Med. 2023;21:189. doi: 10.1186/s12916-023-02893-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12916-023-02893-9</ArticleId><ArticleId IdType="pmc">PMC10206551</ArticleId><ArticleId IdType="pubmed">37226227</ArticleId></ArticleIdList></Reference><Reference><Citation>Patarca R. Cytokines and chronic fatigue syndrome. Ann. N. Y. Acad. Sci. 2001;933:185&#x2013;200. doi: 10.1111/j.1749-6632.2001.tb05824.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.2001.tb05824.x</ArticleId><ArticleId IdType="pubmed">12000020</ArticleId></ArticleIdList></Reference><Reference><Citation>Low R.N., Low R.J., Akrami A. A review of cytokine-based pathophysiology of Long COVID symptoms. Front. Med. 2023;10:1011936. doi: 10.3389/fmed.2023.1011936.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2023.1011936</ArticleId><ArticleId IdType="pmc">PMC10103649</ArticleId><ArticleId IdType="pubmed">37064029</ArticleId></ArticleIdList></Reference><Reference><Citation>Montoya J.G., Holmes T.H., Anderson J.N., Maecker H.T., Rosenberg-Hasson Y., Valencia I.J., Chu L., Younger J.W., Tato C.M., Davis M.M. Cytokine signature associated with disease severity in chronic fatigue syndrome patients. Proc. Natl. Acad. Sci. USA. 2017;114:e7150&#x2013;e7158. doi: 10.1073/pnas.1710519114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1710519114</ArticleId><ArticleId IdType="pmc">PMC5576836</ArticleId><ArticleId IdType="pubmed">28760971</ArticleId></ArticleIdList></Reference><Reference><Citation>Missailidis D., Annesley S.J., Fisher P.R. Pathological mechanisms underlying myalgic encephalomyelitis/chronic fatigue syndrome. Diagnostics. 2019;9:80. doi: 10.3390/diagnostics9030080.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/diagnostics9030080</ArticleId><ArticleId IdType="pmc">PMC6787592</ArticleId><ArticleId IdType="pubmed">31330791</ArticleId></ArticleIdList></Reference><Reference><Citation>Hatziagelaki E., Adamaki M., Tsilioni I., Dimitriadis G., Theoharides T.C. Myalgic encephalomyelitis/chronic fatigue syndrome&#x2014;Metabolic disease or disturbed homeostasis due to focal inflammation in the hypothalamus? J. Pharmacol. Exp. Ther. 2018;367:155&#x2013;167. doi: 10.1124/jpet.118.250845.</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/jpet.118.250845</ArticleId><ArticleId IdType="pubmed">30076265</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Hakeim H.K., Al-Rubaye H.T., Al-Hadrawi D.S., Almulla A.F., Maes M. Long-COVID post-viral chronic fatigue and affective symptoms are associated with oxidative damage, lowered antioxidant defenses and inflammation: A proof of concept and mechanism study. Mol. Psychiatry. 2023;28:564&#x2013;578. doi: 10.1038/s41380-022-01836-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-022-01836-9</ArticleId><ArticleId IdType="pmc">PMC9589528</ArticleId><ArticleId IdType="pubmed">36280755</ArticleId></ArticleIdList></Reference><Reference><Citation>Walker M.O., Hall K.H., Peppercorn K., Tate W.P. The significance of oxidative stress in the pathophysiology of Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Med. Res. Arch. 2022;10 doi: 10.18103/mra.v10i9.3050.</Citation><ArticleIdList><ArticleId IdType="doi">10.18103/mra.v10i9.3050</ArticleId></ArticleIdList></Reference><Reference><Citation>Stufano A., Isgr&#xf2; C., Palese L.L., Caretta P., De Maria L., Lovreglio P., Sardanelli A.M. Oxidative Damage and Post-COVID Syndrome: A Cross-Sectional Study in a Cohort of Italian Workers. Int. J. Mol. Sci. 2023;24:7445. doi: 10.3390/ijms24087445.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms24087445</ArticleId><ArticleId IdType="pmc">PMC10139201</ArticleId><ArticleId IdType="pubmed">37108606</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahaghoghi-Hajghorbani S., Zafari P., Masoumi E., Rajabinejad M., Jafari-Shakib R., Hasani B., Rafiei A. The role of dysregulated immune responses in COVID-19 pathogenesis. Virus Res. 2020;290:198197. doi: 10.1016/j.virusres.2020.198197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2020.198197</ArticleId><ArticleId IdType="pmc">PMC7561578</ArticleId><ArticleId IdType="pubmed">33069815</ArticleId></ArticleIdList></Reference><Reference><Citation>Giamarellos-Bourboulis E.J., Netea M.G., Rovina N., Akinosoglou K., Antoniadou A., Antonakos N., Damoraki G., Gkavogianni T., Adami M.E., Katsaounou P., et al. Complex immune dysregulation in COVID-19 patients with severe respiratory failure. Cell Host Microbe. 2020;27:992&#x2013;1000. doi: 10.1016/j.chom.2020.04.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.04.009</ArticleId><ArticleId IdType="pmc">PMC7172841</ArticleId><ArticleId IdType="pubmed">32320677</ArticleId></ArticleIdList></Reference><Reference><Citation>Paul B.D., Lemle M.D., Komaroff A.L., Snyder S.H. Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome. Proc. Natl. Acad. Sci. USA. 2021;118:e2024358118. doi: 10.1073/pnas.2024358118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2024358118</ArticleId><ArticleId IdType="pmc">PMC8403932</ArticleId><ArticleId IdType="pubmed">34400495</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka S., Kuratsune H., Hidaka Y., Hakariya Y., Tatsumi K.I., Takano T., Kanakura Y., Amino N. Autoantibodies against muscarinic cholinergic receptor in chronic fatigue syndrome. Int. J. Mol. Med. 2003;12:225&#x2013;230. doi: 10.3892/ijmm.12.2.225.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/ijmm.12.2.225</ArticleId><ArticleId IdType="pubmed">12851722</ArticleId></ArticleIdList></Reference><Reference><Citation>Freitag H., Szklarski M., Lorenz S., Sotzny F., Bauer S., Philippe A., Kedor C., Grabowski P., Lange T., Riemekasten G., et al. Autoantibodies to vasoregulative G-protein-coupled receptors correlate with symptom severity, autonomic dysfunction and disability in myalgic encephalomyelitis/chronic fatigue syndrome. J. Clin. Med. 2021;10:3675. doi: 10.3390/jcm10163675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10163675</ArticleId><ArticleId IdType="pmc">PMC8397061</ArticleId><ArticleId IdType="pubmed">34441971</ArticleId></ArticleIdList></Reference><Reference><Citation>Maes M., Twisk F.N., Johnson C. Myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS), and chronic fatigue (CF) are distinguished accurately: Results of supervised learning techniques applied on clinical and inflammatory data. Psychiatry Res. 2012;200:754&#x2013;760. doi: 10.1016/j.psychres.2012.03.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psychres.2012.03.031</ArticleId><ArticleId IdType="pubmed">22521895</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto S., Ouchi Y., Nakatsuka D., Tahara T., Mizuno K., Tajima S., Onoe H., Yoshikawa E., Tsukada H., Iwase M., et al. Reduction of [11C](+)3-MPB binding in brain of chronic fatigue syndrome with serum autoantibody against muscarinic cholinergic receptor. PLoS ONE. 2012;7:e51515. doi: 10.1371/journal.pone.0051515.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0051515</ArticleId><ArticleId IdType="pmc">PMC3519853</ArticleId><ArticleId IdType="pubmed">23240035</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer D.B., William A.H., Strauss A.C., Unger E.R., Jason L.A., Marshall G.D., Jr., Dimitrakoff J.D. Chronic fatigue syndrome: The current status and future potentials of emerging biomarkers. Fatigue Biomed. Health Behav. 2014;2:93&#x2013;109. doi: 10.1080/21641846.2014.906066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21641846.2014.906066</ArticleId><ArticleId IdType="pmc">PMC4052724</ArticleId><ArticleId IdType="pubmed">24932428</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil S., Choudhari S., Raka V., Narkar S., Dahiphale J., Gondhali G. Neurological and systemic manifestations in COVID: Underestimated sequel of COVID&#x2019;s pandora. World J. Adv. Pharm. Med. Res. 2023;4:042&#x2013;052. doi: 10.53346/wjapmr.2023.4.1.0018.</Citation><ArticleIdList><ArticleId IdType="doi">10.53346/wjapmr.2023.4.1.0018</ArticleId></ArticleIdList></Reference><Reference><Citation>Uhde M., Indart A.C., Green P.H., Yolken R.H., Cook D.B., Shukla S.K., Vernon S.D., Alaedini A. Suppressed immune and metabolic responses to intestinal damage-associated microbial translocation in myalgic encephalomyelitis/chronic fatigue syndrome. Brain Behav. Immun. -Health. 2023;30:100627. doi: 10.1016/j.bbih.2023.100627.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbih.2023.100627</ArticleId><ArticleId IdType="pmc">PMC10308215</ArticleId><ArticleId IdType="pubmed">37396339</ArticleId></ArticleIdList></Reference><Reference><Citation>Cliff J.M., King E.C., Lee J.S., Sep&#xfa;lveda N., Wolf A.S., Kingdon C., Bowman E., Dockrell H.M., Nacul L., Lacerda E., et al. Cellular immune function in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) Front. Immunol. 2019;10:422277. doi: 10.3389/fimmu.2019.00796.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2019.00796</ArticleId><ArticleId IdType="pmc">PMC6477089</ArticleId><ArticleId IdType="pubmed">31057538</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller J., Gomez R., Williams G., Lembke A., Lazzeroni L., Murphy G.M., Schatzberg A.F. HPA axis in major depression: Cortisol, clinical symptomatology and genetic variation predict cognition. Mol. Psychiatry. 2017;22:527&#x2013;536. doi: 10.1038/mp.2016.120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2016.120</ArticleId><ArticleId IdType="pmc">PMC5313380</ArticleId><ArticleId IdType="pubmed">27528460</ArticleId></ArticleIdList></Reference><Reference><Citation>Meierovics A., Yankelevich W.J., Cowley S.C. MAIT cells are critical for optimal mucosal immune responses during in vivo pulmonary bacterial infection. Proc. Natl. Acad. Sci. USA. 2013;110:e3119&#x2013;e3128. doi: 10.1073/pnas.1302799110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1302799110</ArticleId><ArticleId IdType="pmc">PMC3746930</ArticleId><ArticleId IdType="pubmed">23898209</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., McCorkell L., Vogel J.M., Topol E.J. Long COVID: Major findings, mechanisms and recommendations. Nat. Rev. Microbiol. 2023;21:133&#x2013;146. doi: 10.1038/s41579-022-00846-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-022-00846-2</ArticleId><ArticleId IdType="pmc">PMC9839201</ArticleId><ArticleId IdType="pubmed">36639608</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C., Che X., Briese T., Ranjan A., Allicock O., Yates R.A., Cheng A., March D., Hornig M., Komaroff A.L., et al. Deficient butyrate-producing capacity in the gut microbiome is associated with bacterial network disturbances and fatigue symptoms in ME/CFS. Cell Host Microbe. 2023;31:288&#x2013;304. doi: 10.1016/j.chom.2023.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2023.01.004</ArticleId><ArticleId IdType="pmc">PMC10183837</ArticleId><ArticleId IdType="pubmed">36758522</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendes de Almeida V., Engel D.F., Ricci M.F., Cruz C.S., Lopes &#xcd;.S., Alves D.A., d&#x2019;Auriol M., Magalh&#xe3;es J., Machado E.C., Rocha V.M., et al. Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms. Gut Microbes. 2023;15:2249146. doi: 10.1080/19490976.2023.2249146.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2023.2249146</ArticleId><ArticleId IdType="pmc">PMC10481883</ArticleId><ArticleId IdType="pubmed">37668317</ArticleId></ArticleIdList></Reference><Reference><Citation>Koc H.C., Xiao J., Liu W., Li Y., Chen G. Long COVID and its management. Int. J. Biol. Sci. 2022;18:4768. doi: 10.7150/ijbs.75056.</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.75056</ArticleId><ArticleId IdType="pmc">PMC9305273</ArticleId><ArticleId IdType="pubmed">35874958</ArticleId></ArticleIdList></Reference><Reference><Citation>Nijs J., Crombez G., Meeus M., Knoop H., Van Damme S., Van Cauwenbergh D., Bleijenberg G. Pain in patients with chronic fatigue syndrome: Time for specific pain treatment? Pain. Physician. 2012;15:E677&#x2013;E686. doi: 10.36076/ppj.2012/15/E677.</Citation><ArticleIdList><ArticleId IdType="doi">10.36076/ppj.2012/15/E677</ArticleId><ArticleId IdType="pubmed">22996861</ArticleId></ArticleIdList></Reference><Reference><Citation>Varesi A., Deumer U.S., Ananth S., Ricevuti G. The emerging role of gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS): Current evidence and potential therapeutic applications. J. Clin. Med. 2021;10:5077. doi: 10.3390/jcm10215077.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm10215077</ArticleId><ArticleId IdType="pmc">PMC8584653</ArticleId><ArticleId IdType="pubmed">34768601</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas N., Gurvich C., Huang K., Gooley P.R., Armstrong C.W. The underlying sex differences in neuroendocrine adaptations relevant to myalgic encephalomyelitis chronic fatigue syndrome. Front. Neuroendocrinol. 2022;66:100995. doi: 10.1016/j.yfrne.2022.100995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.yfrne.2022.100995</ArticleId><ArticleId IdType="pubmed">35421511</ArticleId></ArticleIdList></Reference><Reference><Citation>Aron-Wisnewsky J., Cl&#xe9;ment K. The gut microbiome, diet, and links to cardiometabolic and chronic disorders. Nat. Rev. Nephrol. 2016;12:169&#x2013;181. doi: 10.1038/nrneph.2015.191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneph.2015.191</ArticleId><ArticleId IdType="pubmed">26616538</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazar V., Ditu L.M., Pircalabioru G.G., Picu A., Petcu L., Cucu N., Chifiriuc M.C. Gut microbiota, host organism, and diet trialogue in diabetes and obesity. Front. Nutr. 2019;6:21. doi: 10.3389/fnut.2019.00021.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2019.00021</ArticleId><ArticleId IdType="pmc">PMC6424913</ArticleId><ArticleId IdType="pubmed">30931309</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujimura K.E., Slusher N.A., Cabana M.D., Lynch S.V. Role of the gut microbiota in defining human health. Expert Rev. Anti-Infect. Ther. 2010;8:435&#x2013;454. doi: 10.1586/eri.10.14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/eri.10.14</ArticleId><ArticleId IdType="pmc">PMC2881665</ArticleId><ArticleId IdType="pubmed">20377338</ArticleId></ArticleIdList></Reference><Reference><Citation>Iacob S., Iacob D.G., Luminos L.M. Intestinal microbiota as a host defense mechanism to infectious threats. Front. Microbiol. 2019;9:426119. doi: 10.3389/fmicb.2018.03328.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.03328</ArticleId><ArticleId IdType="pmc">PMC6362409</ArticleId><ArticleId IdType="pubmed">30761120</ArticleId></ArticleIdList></Reference><Reference><Citation>Kho Z.Y., Lal S.K. The human gut microbiome: A potential controller of wellness and disease. Front. Microbiol. 2018;9:356589. doi: 10.3389/fmicb.2018.01835.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.01835</ArticleId><ArticleId IdType="pmc">PMC6102370</ArticleId><ArticleId IdType="pubmed">30154767</ArticleId></ArticleIdList></Reference><Reference><Citation>DeGruttola A.K., Low D., Mizoguchi A., Mizoguchi E. Current understanding of dysbiosis in disease in human and animal models. Inflamm. Bowel Dis. 2016;22:1137&#x2013;1150. doi: 10.1097/MIB.0000000000000750.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MIB.0000000000000750</ArticleId><ArticleId IdType="pmc">PMC4838534</ArticleId><ArticleId IdType="pubmed">27070911</ArticleId></ArticleIdList></Reference><Reference><Citation>Tisza B.B., Iv&#xe1;n G., Keczeli V., K&#xf3;r&#xf3; M., Sz&#xe1;nt&#xf3;ri P., Varga Z.G., M&#xfc;ller H., Prib&#xe9;li O., Szab&#xf3; Z., Verz&#xe1;r Z., et al. A Review of Possible Supplements to Relieve the Symptoms of Fatigue after COVID-19. J. Med. Public Health. 2023;4:37&#x2013;43.</Citation></Reference><Reference><Citation>Shukla S.K., Cook D., Meyer J., Vernon S.D., Le T., Clevidence D., Robertson C.E., Schrodi S.J., Yale S., Frank D.N. Changes in gut and plasma microbiome following exercise challenge in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) PLoS ONE. 2015;10:e0145453. doi: 10.1371/journal.pone.0145453.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0145453</ArticleId><ArticleId IdType="pmc">PMC4684203</ArticleId><ArticleId IdType="pubmed">26683192</ArticleId></ArticleIdList></Reference><Reference><Citation>Navaneetharaja N., Griffiths V., Wileman T., Carding S.R. A role for the intestinal microbiota and virome in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS)? J. Clin. Med. 2016;5:55. doi: 10.3390/jcm5060055.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm5060055</ArticleId><ArticleId IdType="pmc">PMC4929410</ArticleId><ArticleId IdType="pubmed">27275835</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy-Szakal D., Williams B.L., Mishra N., Che X., Lee B., Bateman L., Klimas N.G., Komaroff A.L., Levine S., Montoya J.G., et al. Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. 2017;5:44. doi: 10.1186/s40168-017-0261-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-017-0261-y</ArticleId><ArticleId IdType="pmc">PMC5405467</ArticleId><ArticleId IdType="pubmed">28441964</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo C., Yi B., Wu J., Lu J. The microbiome in post-acute infection syndrome (PAIS) Comput. Struct. Biotechnol. J. 2023;21:3904&#x2013;3911. doi: 10.1016/j.csbj.2023.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.csbj.2023.08.002</ArticleId><ArticleId IdType="pmc">PMC10432703</ArticleId><ArticleId IdType="pubmed">37602232</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva C.F., Motta J.M., Teixeira F.C., Gomes A.M., Vilanova E., Kozlowski E.O., Borsig L., Pav&#xe3;o M.S. Non-anticoagulant heparan sulfate from the ascidian phallusia nigra prevents colon carcinoma metastasis in mice by disrupting platelet-tumor cell interaction. Cancers. 2020;12:1353. doi: 10.3390/cancers12061353.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers12061353</ArticleId><ArticleId IdType="pmc">PMC7352385</ArticleId><ArticleId IdType="pubmed">32466418</ArticleId></ArticleIdList></Reference><Reference><Citation>Estaki M., Pither J., Baumeister P., Little J.P., Gill S.K., Ghosh S., Ahmadi-Vand Z., Marsden K.R., Gibson D.L. Cardiorespiratory fitness as a predictor of intestinal microbial diversity and distinct metagenomic functions. Microbiome. 2016;4:42. doi: 10.1186/s40168-016-0189-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-016-0189-7</ArticleId><ArticleId IdType="pmc">PMC4976518</ArticleId><ArticleId IdType="pubmed">27502158</ArticleId></ArticleIdList></Reference><Reference><Citation>Giloteaux L., Goodrich J.K., Walters W.A., Levine S.M., Ley R.E., Hanson M.R. Reduced diversity and altered composition of the gut microbiome in individuals with myalgic encephalomyelitis/chronic fatigue syndrome. Microbiome. 2016;4:30. doi: 10.1186/s40168-016-0171-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-016-0171-4</ArticleId><ArticleId IdType="pmc">PMC4918027</ArticleId><ArticleId IdType="pubmed">27338587</ArticleId></ArticleIdList></Reference><Reference><Citation>Dumas A., Bernard L., Poquet Y., Lugo-Villarino G., Neyrolles O. The role of the lung microbiota and the gut&#x2013;lung axis in respiratory infectious diseases. Cell. Microbiol. 2018;20:e12966. doi: 10.1111/cmi.12966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cmi.12966</ArticleId><ArticleId IdType="pubmed">30329198</ArticleId></ArticleIdList></Reference><Reference><Citation>Budden K.F., Gellatly S.L., Wood D.L., Cooper M.A., Morrison M., Hugenholtz P., Hansbro P.M. Emerging pathogenic links between microbiota and the gut&#x2013;lung axis. Nat. Rev. Microbiol. 2017;15:55&#x2013;63. doi: 10.1038/nrmicro.2016.142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2016.142</ArticleId><ArticleId IdType="pubmed">27694885</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R.X., Zhou M., Ma H.L., Qiao Y.B., Li Q.S. The role of chronic inflammation in various diseases and anti-inflammatory therapies containing natural products. ChemMedChem. 2021;16:1576&#x2013;1592. doi: 10.1002/cmdc.202000996.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cmdc.202000996</ArticleId><ArticleId IdType="pubmed">33528076</ArticleId></ArticleIdList></Reference><Reference><Citation>Binda C., Lopetuso L.R., Rizzatti G., Gibiino G., Cennamo V., Gasbarrini A. Actinobacteria: A relevant minority for the maintenance of gut homeostasis. Dig. Liver Dis. 2018;50:421&#x2013;428. doi: 10.1016/j.dld.2018.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2018.02.012</ArticleId><ArticleId IdType="pubmed">29567414</ArticleId></ArticleIdList></Reference><Reference><Citation>Simpson C.A., Diaz-Arteche C., Eliby D., Schwartz O.S., Simmons J.G., Cowan C.S. The gut microbiota in anxiety and depression: A systematic review. Clin. Psychol. Rev. 2021;83:101943. doi: 10.1016/j.cpr.2020.101943.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpr.2020.101943</ArticleId><ArticleId IdType="pubmed">33271426</ArticleId></ArticleIdList></Reference><Reference><Citation>Alenazy M.F., Aljohar H.I., Alruwaili A.R., Daghestani M.H., Alonazi M.A., Labban R.S., El-Ansary A.K., Balto H.A. Gut microbiota dynamics in relation to long-COVID-19 syndrome: Role of probiotics to combat psychiatric complications. Metabolites. 2022;12:912. doi: 10.3390/metabo12100912.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo12100912</ArticleId><ArticleId IdType="pmc">PMC9611210</ArticleId><ArticleId IdType="pubmed">36295814</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeoh Y.K., Zuo T., Lui G.C., Zhang F., Liu Q., Li A.Y., Chung A.C., Cheung C.P., Tso E.Y., Fung K.S., et al. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19. Gut. 2021;70:698&#x2013;706. doi: 10.1136/gutjnl-2020-323020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-323020</ArticleId><ArticleId IdType="pmc">PMC7804842</ArticleId><ArticleId IdType="pubmed">33431578</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen J., Hall S., Vitetta L. Altered gut microbial metabolites could mediate the effects of risk factors in COVID-19. Rev. Med. Virol. 2021;31:1&#x2013;13. doi: 10.1002/rmv.2211.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/rmv.2211</ArticleId><ArticleId IdType="pmc">PMC7995004</ArticleId><ArticleId IdType="pubmed">34546607</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y., Ran H., Wen X., Fu G., Zhou X., Liu R., Pan T. Probiotics improve symptoms of patients with COVID-19 through gut-lung axis: A systematic review and meta-analysis. Front. Nutr. 2023;10:1179432. doi: 10.3389/fnut.2023.1179432.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1179432</ArticleId><ArticleId IdType="pmc">PMC10239816</ArticleId><ArticleId IdType="pubmed">37284648</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira C., Viana S.D., Reis F. Gut microbiota dysbiosis&#x2013;immune hyperresponse&#x2013;inflammation triad in coronavirus disease 2019 (COVID-19): Impact of pharmacological and nutraceutical approaches. Microorganisms. 2020;8:1514. doi: 10.3390/microorganisms8101514.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8101514</ArticleId><ArticleId IdType="pmc">PMC7601735</ArticleId><ArticleId IdType="pubmed">33019592</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Wu X., Wen W., Lan P. Gut microbiome alterations in COVID-19. Genom. Proteom. Bioinform. 2021;19:679&#x2013;688. doi: 10.1016/j.gpb.2021.09.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gpb.2021.09.004</ArticleId><ArticleId IdType="pmc">PMC8478109</ArticleId><ArticleId IdType="pubmed">34560321</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q., Mak J.W., Su Q., Yeoh Y.K., Lui G.C., Ng S.S., Zhang F., Li A.Y., Lu W., Hui D.S., et al. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022;71:544&#x2013;552. doi: 10.1136/gutjnl-2021-325989.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2021-325989</ArticleId><ArticleId IdType="pubmed">35082169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Zhou Y., Ma Y., Chen P., Tang J., Yang B., Li H., Liang M., Xue Y., Liu Y., et al. Gut microbiota dysbiosis correlates with long COVID-19 at one-year after discharge. J. Korean Med. Sci. 2023;38:e120. doi: 10.3346/jkms.2023.38.e120.</Citation><ArticleIdList><ArticleId IdType="doi">10.3346/jkms.2023.38.e120</ArticleId><ArticleId IdType="pmc">PMC10111044</ArticleId><ArticleId IdType="pubmed">37069814</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y., Xu J., Chen Y. Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders. Nutrients. 2021;13:2099. doi: 10.3390/nu13062099.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13062099</ArticleId><ArticleId IdType="pmc">PMC8234057</ArticleId><ArticleId IdType="pubmed">34205336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortelli P., Ferrazzoli D., Sebastianelli L., Maestri R., Dezi S., Spampinato D., Saltuari L., Alibardi A., Engl M., Kofler M., et al. Altered motor cortex physiology and dysexecutive syndrome in patients with fatigue and cognitive difficulties after mild COVID-19. Eur. J. Neurol. 2022;29:1652&#x2013;1662. doi: 10.1111/ene.15278.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ene.15278</ArticleId><ArticleId IdType="pmc">PMC9111319</ArticleId><ArticleId IdType="pubmed">35138693</ArticleId></ArticleIdList></Reference><Reference><Citation>Manganotti P., Michelutti M., Furlanis G., Deodato M., Stella A.B. Deficient GABABergic and glutamatergic excitability in the motor cortex of patients with long-COVID and cognitive impairment. Clin. Neurophysiol. 2023;151:83&#x2013;91. doi: 10.1016/j.clinph.2023.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2023.04.010</ArticleId><ArticleId IdType="pmc">PMC10170904</ArticleId><ArticleId IdType="pubmed">37210757</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill C., Guarner F., Reid G., Gibson G.R., Merenstein D.J., Pot B., Morelli L., Canani R.B., Flint H.J., Salminen S., et al. Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014;11:506&#x2013;514. doi: 10.1038/nrgastro.2014.66.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrgastro.2014.66</ArticleId><ArticleId IdType="pubmed">24912386</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahbazi R., Yasavoli-Sharahi H., Alsadi N., Ismail N., Matar C. Probiotics in treatment of viral respiratory infections and neuroinflammatory disorders. Molecules. 2020;25:4891. doi: 10.3390/molecules25214891.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25214891</ArticleId><ArticleId IdType="pmc">PMC7660077</ArticleId><ArticleId IdType="pubmed">33105830</ArticleId></ArticleIdList></Reference><Reference><Citation>Sandionigi A., De Giani A., Tursi F., Michelotti A., Cestone E., Giardina S., Zampolli J., Di Gennaro P. Effectiveness of multistrain probiotic formulation on common infectious disease symptoms and gut microbiota modulation in flu-vaccinated healthy elderly subjects. BioMed Res. Int. 2022;2022:3860896. doi: 10.1155/2022/3860896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2022/3860896</ArticleId><ArticleId IdType="pmc">PMC8814717</ArticleId><ArticleId IdType="pubmed">35127941</ArticleId></ArticleIdList></Reference><Reference><Citation>Farzi A., Fr&#xf6;hlich E.E., Holzer P. Gut microbiota and the neuroendocrine system. Neurotherapeutics. 2018;15:5&#x2013;22. doi: 10.1007/s13311-017-0600-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13311-017-0600-5</ArticleId><ArticleId IdType="pmc">PMC5794709</ArticleId><ArticleId IdType="pubmed">29380303</ArticleId></ArticleIdList></Reference><Reference><Citation>Buglione-Corbett R., Deligiannidis K.M., Leung K., Zhang N., Lee M., Rosal M.C., Moore Simas T.A. Expression of inflammatory markers in women with perinatal depressive symptoms. Arch. Women&#x2019;s Ment. Health. 2018;21:671&#x2013;679. doi: 10.1007/s00737-018-0834-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00737-018-0834-1</ArticleId><ArticleId IdType="pubmed">29603018</ArticleId></ArticleIdList></Reference><Reference><Citation>Aziz T., Naveed M. Integrated genome based evaluation of safety and probiotic characteristics of Lactiplantibacillus plantarum YW11 isolated from Tibetan kefir. Front. Microbiol. 2023;14:1157615. doi: 10.3389/fmicb.2023.1157615.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2023.1157615</ArticleId><ArticleId IdType="pmc">PMC10158936</ArticleId><ArticleId IdType="pubmed">37152722</ArticleId></ArticleIdList></Reference><Reference><Citation>Rao A.V., Bested A.C., Beaulne T.M., Katzman M.A., Iorio C., Berardi J.M., Logan A.C. A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog. 2009;1:6. doi: 10.1186/1757-4749-1-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1757-4749-1-6</ArticleId><ArticleId IdType="pmc">PMC2664325</ArticleId><ArticleId IdType="pubmed">19338686</ArticleId></ArticleIdList></Reference><Reference><Citation>Venturini L., Bacchi S., Capelli E., Lorusso L., Ricevuti G., Cusa C. Modification of immunological parameters, oxidative stress markers, mood symptoms, and well-being status in CFS patients after probiotic intake: Observations from a pilot study. Oxidative Med. Cell. Longev. 2019;2019:1684198. doi: 10.1155/2019/1684198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2019/1684198</ArticleId><ArticleId IdType="pmc">PMC6906814</ArticleId><ArticleId IdType="pubmed">31871540</ArticleId></ArticleIdList></Reference><Reference><Citation>Williamson C.B., Burns C.M., Gossard C.M., Pizano J.M., Dolan K.E., Finley H.J., Gasta M.G., Parker E.C., Lipski E.A. Probiotics and disease: A comprehensive summary&#x2014;Part 3, Cardiometabolic disease and fatigue syndromes. Integr. Med. Clin. J. 2017;16:30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5312743</ArticleId><ArticleId IdType="pubmed">28223906</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathi A., Jadhav S.B., Shah N. A randomized controlled trial of the efficacy of systemic enzymes and probiotics in the resolution of post-COVID fatigue. Medicines. 2021;8:47. doi: 10.3390/medicines8090047.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicines8090047</ArticleId><ArticleId IdType="pmc">PMC8472462</ArticleId><ArticleId IdType="pubmed">34564089</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L., Yang C.S., Liu Y., Zhang X. Effective regulation of gut microbiota with probiotics and prebiotics may prevent or alleviate COVID-19 through the gut-lung axis. Front. Pharmacol. 2022;13:895193. doi: 10.3389/fphar.2022.895193.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.895193</ArticleId><ArticleId IdType="pmc">PMC9081431</ArticleId><ArticleId IdType="pubmed">35548347</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohail A., Cheema H.A., Mithani M.S., Shahid A., Nawaz A., Hermis A.H., Chinnam S., Nashwan A.J., Cherrez-Ojeda I., Awan R.U., et al. Probiotics for the prevention and treatment of COVID-19: A rapid systematic review and meta-analysis. Front. Nutr. 2023;10:1274122. doi: 10.3389/fnut.2023.1274122.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2023.1274122</ArticleId><ArticleId IdType="pmc">PMC10641770</ArticleId><ArticleId IdType="pubmed">37964926</ArticleId></ArticleIdList></Reference><Reference><Citation>Roman P., Est&#xe9;vez A.F., Miras A., S&#xe1;nchez-Labraca N., Ca&#xf1;adas F., Vivas A.B., Cardona D. A pilot randomized controlled trial to explore cognitive and emotional effects of probiotics in fibromyalgia. Sci. Rep. 2018;8:10965. doi: 10.1038/s41598-018-29388-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-29388-5</ArticleId><ArticleId IdType="pmc">PMC6053373</ArticleId><ArticleId IdType="pubmed">30026567</ArticleId></ArticleIdList></Reference><Reference><Citation>Sullivan &#xc5;., Nord C.E., Eveng&#xe5;rd B. Effect of supplement with lactic-acid producing bacteria on fatigue and physical activity in patients with chronic fatigue syndrome. Nutr. J. 2009;8:4. doi: 10.1186/1475-2891-8-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2891-8-4</ArticleId><ArticleId IdType="pmc">PMC2642862</ArticleId><ArticleId IdType="pubmed">19171024</ArticleId></ArticleIdList></Reference><Reference><Citation>Santinelli L., Laghi L., Innocenti G.P., Pinacchio C., Vassalini P., Celani L., Lazzaro A., Borrazzo C., Marazzato M., Tarsitani L., et al. Oral bacteriotherapy reduces the occurrence of chronic fatigue in COVID-19 patients. Front. Nutr. 2022;8:1139. doi: 10.3389/fnut.2021.756177.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnut.2021.756177</ArticleId><ArticleId IdType="pmc">PMC8790565</ArticleId><ArticleId IdType="pubmed">35096923</ArticleId></ArticleIdList></Reference><Reference><Citation>Caprioli F., Marinoni B., Rimondi A., Bottaro F., Ciafardini C., Amoroso C., Muia M., Caridi B., Noviello D., Bandera A., et al. The Role of VSL#3&#x174; in the Treatment of Fatigue and Other Symptoms in Long COVID-19 Syndrome: A Randomized, Double-blind, Placebo-controlled Pilot Study (DELong#3) medRxiv. 2023 doi: 10.1101/2023.06.28.23291986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2023.06.28.23291986</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalitsuradej E., Sirilun S., Sittiprapaporn P., Sivamaruthi B.S., Pintha K., Tantipaiboonwong P., Khongtan S., Fukngoen P., Peerajan S., Chaiyasut C. The effects of synbiotics administration on stress-related parameters in Thai subjects: A preliminary study. Foods. 2022;11:759. doi: 10.3390/foods11050759.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/foods11050759</ArticleId><ArticleId IdType="pmc">PMC8909555</ArticleId><ArticleId IdType="pubmed">35267392</ArticleId></ArticleIdList></Reference><Reference><Citation>d&#x2019;Ettorre G., Ceccarelli G., Marazzato M., Campagna G., Pinacchio C., Alessandri F., Ruberto F., Rossi G., Celani L., Scagnolari C., et al. Challenges in the management of SARS-CoV-2 infection: The role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19. Front. Med. 2020;7:389. doi: 10.3389/fmed.2020.00389.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00389</ArticleId><ArticleId IdType="pmc">PMC7358304</ArticleId><ArticleId IdType="pubmed">32733907</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas R., Williams M., Aldous J., Yanagisawa Y., Kumar R., Forsyth R., Chater A. A randomised, double-blind, placebo-controlled trial evaluating concentrated phytochemical-rich nutritional capsule in addition to a probiotic capsule on clinical outcomes among individuals with COVID-19: The UK Phyto-V study. COVID. 2022;2:433&#x2013;449. doi: 10.3390/covid2040031.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/covid2040031</ArticleId></ArticleIdList></Reference><Reference><Citation>Hinchado M.D., Quero-Calero C.D., Otero E., G&#xe1;lvez I., Ortega E. Synbiotic Supplementation Improves Quality of Life and Inmunoneuroendocrine Response in Patients with Fibromyalgia: Influence of Codiagnosis with Chronic Fatigue Syndrome. Nutrients. 2023;15:1591. doi: 10.3390/nu15071591.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15071591</ArticleId><ArticleId IdType="pmc">PMC10097287</ArticleId><ArticleId IdType="pubmed">37049432</ArticleId></ArticleIdList></Reference><Reference><Citation>Obermoser K., Brigo N., Schroll A., Monfort-Lanzas P., Gostner J.M., Engl S., Geisler S., Knoll M., Schennach H., Weiss G., et al. Positive effects of probiotic therapy in patients with post-infectious fatigue. Metabolites. 2023;13:639. doi: 10.3390/metabo13050639.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/metabo13050639</ArticleId><ArticleId IdType="pmc">PMC10221065</ArticleId><ArticleId IdType="pubmed">37233680</ArticleId></ArticleIdList></Reference><Reference><Citation>Jason L.A., Natelson B.H., Bonilla H., Sherif Z.A., Vernon S.D., Gutierrez M.V., O&#x2019;Brien L., Taylor E. What Long COVID investigators can learn from four decades of ME/CFS research. Brain Behav. Immun. Integr. 2023;4:100022. doi: 10.1016/j.bbii.2023.100022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbii.2023.100022</ArticleId></ArticleIdList></Reference><Reference><Citation>Groeger D., O&#x2019;Mahony L., Murphy E.F., Bourke J.F., Dinan T.G., Kiely B., Shanahan F., Quigley E.M. Bifidobacterium infantis 35624 modulates host inflammatory processes beyond the gut. Gut Microbes. 2013;4:325&#x2013;339. doi: 10.4161/gmic.25487.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/gmic.25487</ArticleId><ArticleId IdType="pmc">PMC3744517</ArticleId><ArticleId IdType="pubmed">23842110</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomkinson S., Triscott C., Schenk E., Foey A. The potential of probiotics as ingestible adjuvants and immune modulators for antiviral immunity and management of SARS-CoV-2 infection and COVID-19. Pathogens. 2023;12:928. doi: 10.3390/pathogens12070928.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens12070928</ArticleId><ArticleId IdType="pmc">PMC10384479</ArticleId><ArticleId IdType="pubmed">37513775</ArticleId></ArticleIdList></Reference><Reference><Citation>Khokhlova E., Colom J., Simon A., Mazhar S., Garc&#xed;a-Lainez G., Llopis S., Gonzalez N., Enrique-L&#xf3;pez M., &#xc1;lvarez B., Martorell P., et al. Immunomodulatory and antioxidant properties of a novel potential probiotic Bacillus clausii CSI08. Microorganisms. 2023;11:240. doi: 10.3390/microorganisms11020240.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11020240</ArticleId><ArticleId IdType="pmc">PMC9962608</ArticleId><ArticleId IdType="pubmed">36838205</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross K. Psychobiotics: Are they the future intervention for managing depression and anxiety? A literature review. Explore. 2023;19:669&#x2013;680. doi: 10.1016/j.explore.2023.02.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.explore.2023.02.007</ArticleId><ArticleId IdType="pmc">PMC9940471</ArticleId><ArticleId IdType="pubmed">36868988</ArticleId></ArticleIdList></Reference><Reference><Citation>Warda A.K., Rea K., Fitzgerald P., Hueston C., Gonzalez-Tortuero E., Dinan T.G., Hill C. Heat-killed lactobacilli alter both microbiota composition and behaviour. Behav. Brain Res. 2019;362:213&#x2013;223. doi: 10.1016/j.bbr.2018.12.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2018.12.047</ArticleId><ArticleId IdType="pubmed">30597248</ArticleId></ArticleIdList></Reference><Reference><Citation>Zieli&#x144;ska D., Karbowiak M., Brzezicka A. The Role of Psychobiotics to Ensure Mental Health during the COVID-19 Pandemic&#x2014;A Current State of Knowledge. Int. J. Environ. Res. Public Health. 2022;19:11022. doi: 10.3390/ijerph191711022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph191711022</ArticleId><ArticleId IdType="pmc">PMC9518511</ArticleId><ArticleId IdType="pubmed">36078738</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma R., Gupta D., Mehrotra R., Mago P. Psychobiotics: The next-generation probiotics for the brain. Curr. Microbiol. 2021;78:449&#x2013;463. doi: 10.1007/s00284-020-02289-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00284-020-02289-5</ArticleId><ArticleId IdType="pubmed">33394083</ArticleId></ArticleIdList></Reference><Reference><Citation>Miyaoka T., Kanayama M., Wake R., Hashioka S., Hayashida M., Nagahama M., Okazaki S., Yamashita S., Miura S., Miki H., et al. Clostridium butyricum MIYAIRI 588 as adjunctive therapy for treatment-resistant major depressive disorder: A prospective open-label trial. Clin. Neuropharmacol. 2018;41:151&#x2013;155. doi: 10.1097/WNF.0000000000000299.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WNF.0000000000000299</ArticleId><ArticleId IdType="pubmed">30234616</ArticleId></ArticleIdList></Reference><Reference><Citation>Diop L., Guillou S., Durand H. Probiotic food supplement reduces stress-induced gastrointestinal symptoms in volunteers: A double-blind, placebo-controlled, randomized trial. Nutr. Res. 2008;28:1&#x2013;5. doi: 10.1016/j.nutres.2007.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nutres.2007.10.001</ArticleId><ArticleId IdType="pubmed">19083380</ArticleId></ArticleIdList></Reference><Reference><Citation>Eskandarzadeh S., Effatpanah M., Khosravi-Darani K., Askari R., Hosseini A.F., Reisian M., Jazayeri S. Efficacy of a multispecies probiotic as adjunctive therapy in generalized anxiety disorder: A double blind, randomized, placebo-controlled trial. Nutr. Neurosci. 2021;24:102&#x2013;108. doi: 10.1080/1028415X.2019.1598669.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2019.1598669</ArticleId><ArticleId IdType="pubmed">31516094</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohammadi A.A., Jazayeri S., Khosravi-Darani K., Solati Z., Mohammadpour N., Asemi Z., Adab Z., Djalali M., Tehrani-Doost M., Hosseini M., et al. The effects of probiotics on mental health and hypothalamic&#x2013;pituitary&#x2013;adrenal axis: A randomized, double-blind, placebo-controlled trial in petrochemical workers. Nutr. Neurosci. 2016;19:387&#x2013;395. doi: 10.1179/1476830515Y.0000000023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1476830515Y.0000000023</ArticleId><ArticleId IdType="pubmed">25879690</ArticleId></ArticleIdList></Reference><Reference><Citation>Akkasheh G., Kashani-Poor Z., Tajabadi-Ebrahimi M., Jafari P., Akbari H., Taghizadeh M., Memarzadeh M.R., Asemi Z., Esmaillzadeh A. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition. 2016;32:315&#x2013;320. doi: 10.1016/j.nut.2015.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nut.2015.09.003</ArticleId><ArticleId IdType="pubmed">26706022</ArticleId></ArticleIdList></Reference><Reference><Citation>Marotta A., Sarno E., Del Casale A., Pane M., Mogna L., Amoruso A., Felis G.E., Fiorio M. Effects of probiotics on cognitive reactivity, mood, and sleep quality. Front. Psychiatry. 2019;10:427235. doi: 10.3389/fpsyt.2019.00164.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2019.00164</ArticleId><ArticleId IdType="pmc">PMC6445894</ArticleId><ArticleId IdType="pubmed">30971965</ArticleId></ArticleIdList></Reference><Reference><Citation>Ait-Belgnaoui A., Colom A., Braniste V., Ramalho L., Marrot A., Cartier C., Houdeau E., Theodorou V., Tompkins T. Probiotic gut effect prevents the chronic psychological stress-induced brain activity abnormality in mice. Neurogastroenterol. Motil. 2014;26:510&#x2013;520. doi: 10.1111/nmo.12295.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nmo.12295</ArticleId><ArticleId IdType="pubmed">24372793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghorbani Z., Nazari S., Etesam F., Nourimajd S., Ahmadpanah M., Jahromi S.R. The effect of symbiotic as an adjuvant therapy to fluoxetine in moderate depression: A randomized multicenter trial. Arch. Neurosci. 2018;5:e60507. doi: 10.5812/archneurosci.60507.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/archneurosci.60507</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson H., Tullberg C., Ahrn&#xe9; S., Hamberg K., Lazou Ahr&#xe9;n I., Molin G., Sonesson M., H&#xe5;kansson &#xc5;. Oral administration of Lactobacillus plantarum 299v reduces cortisol levels in human saliva during examination induced stress: A randomized, double-blind controlled trial. Int. J. Microbiol. 2016;2016:8469018. doi: 10.1155/2016/8469018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2016/8469018</ArticleId><ArticleId IdType="pmc">PMC5217173</ArticleId><ArticleId IdType="pubmed">28101105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lennartsson A.K., Theorell T., Kushnir M.M., Bergquist J., Jonsdottir I.H. Perceived stress at work is associated with attenuated DHEA-S response during acute psychosocial stress. Psychoneuroendocrinology. 2013;38:1650&#x2013;1657. doi: 10.1016/j.psyneuen.2013.01.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psyneuen.2013.01.010</ArticleId><ArticleId IdType="pubmed">23428256</ArticleId></ArticleIdList></Reference><Reference><Citation>Morris G., Anderson G., Maes M. Hypothalamic-pituitary-adrenal hypofunction in myalgic encephalomyelitis/chronic fatigue syndrome as a consequence of activated immune-inflammatory and oxidative and nitrosative pathways. Mol. Neurobiol. 2017;54:6806&#x2013;6819. doi: 10.1007/s12035-016-0170-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-016-0170-2</ArticleId><ArticleId IdType="pubmed">27766535</ArticleId></ArticleIdList></Reference><Reference><Citation>Lau H.C., Ng S.C., Yu J. Targeting the Gut Microbiota in Coronavirus Disease 2019: Hype or Hope? Gastroenterology. 2022;162:9&#x2013;16. doi: 10.1053/j.gastro.2021.09.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2021.09.009</ArticleId><ArticleId IdType="pmc">PMC8425294</ArticleId><ArticleId IdType="pubmed">34508775</ArticleId></ArticleIdList></Reference><Reference><Citation>Thye A.Y., Law J.W., Tan L.T., Pusparajah P., Ser H.L., Thurairajasingam S., Letchumanan V., Lee L.H. Psychological Symptoms in COVID-19 Patients: Insights into Pathophysiology and Risk Factors of Long COVID-19. Biology. 2022;11:61. doi: 10.3390/biology11010061.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biology11010061</ArticleId><ArticleId IdType="pmc">PMC8773222</ArticleId><ArticleId IdType="pubmed">35053059</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Toro-Barbosa M., Hurtado-Romero A., Garcia-Amezquita L.E., Garc&#xed;a-Cayuela T. Psychobiotics: Mechanisms of action, evaluation methods and effectiveness in applications with food products. Nutrients. 2020;12:3896. doi: 10.3390/nu12123896.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu12123896</ArticleId><ArticleId IdType="pmc">PMC7767237</ArticleId><ArticleId IdType="pubmed">33352789</ArticleId></ArticleIdList></Reference><Reference><Citation>Corbitt M., Campagnolo N., Staines D., Marshall-Gradisnik S. A systematic review of probiotic interventions for gastrointestinal symptoms and irritable bowel syndrome in chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) Probiotics Antimicrob. Proteins. 2018;10:466&#x2013;477. doi: 10.1007/s12602-018-9397-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12602-018-9397-8</ArticleId><ArticleId IdType="pubmed">29464501</ArticleId></ArticleIdList></Reference><Reference><Citation>Choudhury A., Tariq R., Jena A., Vesely E.K., Singh S., Khanna S., Sharma V. Gastrointestinal manifestations of long COVID: A systematic review and meta-analysis. Ther. Adv. Gastroenterol. 2022;15:17562848221118403. doi: 10.1177/17562848221118403.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/17562848221118403</ArticleId><ArticleId IdType="pmc">PMC9393939</ArticleId><ArticleId IdType="pubmed">36004306</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty C., Sharma A.R., Bhattacharya M., Dhama K., Lee S.S. Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity. World J. Gastroenterol. 2022;28:2802&#x2013;2822. doi: 10.3748/wjg.v28.i25.2802.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.v28.i25.2802</ArticleId><ArticleId IdType="pmc">PMC9280735</ArticleId><ArticleId IdType="pubmed">35978881</ArticleId></ArticleIdList></Reference><Reference><Citation>Lymberopoulos E., Gentili G.I., Budhdeo S., Sharma N. COVID-19 severity is associated with population-level gut microbiome variations. Front. Cell Infect. Microbiol. 2022;12:963338. doi: 10.3389/fcimb.2022.963338.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.963338</ArticleId><ArticleId IdType="pmc">PMC9445151</ArticleId><ArticleId IdType="pubmed">36081770</ArticleId></ArticleIdList></Reference><Reference><Citation>Sfera A., Osorio C., Hazan S., Kozlakidis Z., Maldonado J.C., Zapata-Mart&#xed;n del Campo C.M., Anton J.J., Rahman L., Andronescu C.V., Nicolson G.L. Long COVID and the Neuroendocrinology of Microbial Translocation Outside the GI Tract: Some Treatment Strategies. Endocrines. 2022;3:703&#x2013;725. doi: 10.3390/endocrines3040058.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/endocrines3040058</ArticleId></ArticleIdList></Reference><Reference><Citation>Geirnaert A., Calatayud M., Grootaert C., Laukens D., Devriese S., Smagghe G., De Vos M., Boon N., Van de Wiele T. Butyrate-producing bacteria supplemented in vitro to Crohn&#x2019;s disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity. Sci. Rep. 2017;7:11450. doi: 10.1038/s41598-017-11734-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-11734-8</ArticleId><ArticleId IdType="pmc">PMC5597586</ArticleId><ArticleId IdType="pubmed">28904372</ArticleId></ArticleIdList></Reference><Reference><Citation>Homayouni-Rad A., Soleimani R.A., Khani N. Can postbiotics prevent or improve SARS-CoV-2? Curr. Nutr. Food Sci. 2023;19:756&#x2013;757. doi: 10.2174/1573401318666221004112500.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1573401318666221004112500</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson D., Thurairajasingam S., Letchumanan V., Chan K.G., Lee L.H. Exploring the role and potential of probiotics in the field of mental health: Major depressive disorder. Nutrients. 2021;13:1728. doi: 10.3390/nu13051728.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13051728</ArticleId><ArticleId IdType="pmc">PMC8161395</ArticleId><ArticleId IdType="pubmed">34065187</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>